Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
Author:
Affiliation:
1. Discovery Research Laboratory for Core Therapeutic Areas, Shionogi & Co., Ltd., Osaka, Japan
2. Toho University School of Medicine, Tokyo, Japan
3. Global Innovation Office, Shionogi & Co., Ltd., Osaka, Japan
Abstract
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Link
https://journals.asm.org/doi/pdf/10.1128/AAC.03098-15
Reference14 articles.
1. Carbapenemases: the Versatile β-Lactamases
2. Emerging carbapenemases: a global perspective
3. Carbapenemase-producing Enterobacteriaceae: Overview of a major public health challenge
4. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control
5. Acinetobacter baumannii : Emergence of a Successful Pathogen
Cited by 153 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pharmacokinetics, Safety and Tolerability of Single-dose or Multiple-dose Cefiderocol in Hospitalized Pediatric Patients Three Months to Less Than Eighteen Years Old With Infections Treated With Standard-of-care Antibiotics in the PEDI-CEFI Phase 2 Study;Pediatric Infectious Disease Journal;2024-09-04
2. Cefiderocol: a first and novel class of siderophore cephalosporin for Carbapenem-resistant Gram-negative infection;Folia Pharmacologica Japonica;2024-09-01
3. Location, Location, Location: Establishing Design Principles for New Antibacterials from Ferric Siderophore Transport Systems;Molecules;2024-08-16
4. In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations;Microbiology Spectrum;2024-08-06
5. Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria;Cells;2024-08-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3